MRE-269 [475085-57-5]

TargetMol Chemicals

MRE-269 [475085-57-5]

4

475085-57-5

Chemical

Research Use Only

MRE-269

99.57%

C25H29N3O3

419.52

MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269(ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269(ACT-333679) is an active metabolite of Selexipag (S253150).

3 years

N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3

-20°C

12352200